103 related articles for article (PubMed ID: 8618054)
1. Low frequency of loss of heterozygosity at the nevoid basal cell carcinoma locus and other selected loci in appendageal tumors.
Takata M; Quinn AG; Hashimoto K; Rees JL
J Invest Dermatol; 1996 May; 106(5):1141-4. PubMed ID: 8618054
[TBL] [Abstract][Full Text] [Related]
2. Delineation of two distinct deleted regions on chromosome 9 in human non-melanoma skin cancers.
Quinn AG; Sikkink S; Rees JL
Genes Chromosomes Cancer; 1994 Dec; 11(4):222-5. PubMed ID: 7533525
[TBL] [Abstract][Full Text] [Related]
3. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss.
Quinn AG; Sikkink S; Rees JL
Cancer Res; 1994 Sep; 54(17):4756-9. PubMed ID: 8062275
[TBL] [Abstract][Full Text] [Related]
4. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma.
Gailani MR; Leffell DJ; Ziegler A; Gross EG; Brash DE; Bale AE
J Natl Cancer Inst; 1996 Mar; 88(6):349-54. PubMed ID: 8609643
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 9 allele loss occurs in both basal and squamous cell carcinomas of the skin.
Quinn AG; Campbell C; Healy E; Rees JL
J Invest Dermatol; 1994 Mar; 102(3):300-3. PubMed ID: 8120412
[TBL] [Abstract][Full Text] [Related]
6. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal origin of anatomically distinct basal cell carcinomas.
Shulman O; Laitman Y; Vilan A; Leviav A; Friedman E
J Invest Dermatol; 2006 Mar; 126(3):676-9. PubMed ID: 16410785
[TBL] [Abstract][Full Text] [Related]
8. Analysis of p53 gene mutations and loss of heterozygosity for loci on chromosome 9q in basal cell carcinoma.
Konishi K; Yamanishi K; Ishizaki K; Yamada K; Kishimoto S; Yasuno H
Cancer Lett; 1994 Apr; 79(1):67-72. PubMed ID: 8187055
[TBL] [Abstract][Full Text] [Related]
9. Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.
Holmberg E; Rozell BL; Toftgård R
Br J Cancer; 1996 Jul; 74(2):246-50. PubMed ID: 8688329
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.
Waring AJ; Takata M; Rehman I; Rees JL
Br J Cancer; 1996 Mar; 73(5):649-53. PubMed ID: 8605102
[TBL] [Abstract][Full Text] [Related]
11. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele.
van der Riet P; Karp D; Farmer E; Wei Q; Grossman L; Tokino K; Ruppert JM; Sidransky D
Cancer Res; 1994 Jan; 54(1):25-7. PubMed ID: 8261448
[TBL] [Abstract][Full Text] [Related]
12. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
13. Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event.
Teh MT; Blaydon D; Chaplin T; Foot NJ; Skoulakis S; Raghavan M; Harwood CA; Proby CM; Philpott MP; Young BD; Kelsell DP
Cancer Res; 2005 Oct; 65(19):8597-603. PubMed ID: 16204023
[TBL] [Abstract][Full Text] [Related]
14. Detection of loss of heterozygosity on chromosome 9q22.3 in microdissected sporadic basal cell carcinoma.
Shen T; Park WS; Böni R; Saini N; Pham T; Lash AE; Vortmeyer AO; Zhuang Z
Hum Pathol; 1999 Mar; 30(3):284-7. PubMed ID: 10088546
[TBL] [Abstract][Full Text] [Related]
15. High frequency of loss of heterozygosity on chromosome region 9p21-p22 but lack of p16INK4a/p19ARF mutations in greek patients with basal cell carcinoma of the skin.
Saridaki Z; Koumantaki E; Liloglou T; Sourvinos G; Papadopoulos O; Zoras O; Spandidos DA
J Invest Dermatol; 2000 Oct; 115(4):719-25. PubMed ID: 10998150
[TBL] [Abstract][Full Text] [Related]
16. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.
Sato S; Nakamura Y; Tsuchiya E
Cancer Res; 1994 Nov; 54(21):5652-5. PubMed ID: 7923212
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the c-Ha-ras-1 allele in human skin cancers.
Ananthaswamy HN; Applegate LA; Goldberg LH; Bales ES
Mol Carcinog; 1989; 2(5):298-301. PubMed ID: 2690853
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses.
Harms PW; Fullen DR; Patel RM; Chang D; Shalin SC; Ma L; Wood B; Beer TW; Siddiqui J; Carskadon S; Wang M; Palanisamy N; Fisher GJ; Andea A
Hum Pathol; 2015 May; 46(5):690-7. PubMed ID: 25704628
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels.
Hatta N; Hirano T; Kimura T; Hashimoto K; Mehregan DR; Ansai S; Takehara K; Takata M
J Cutan Pathol; 2005 Feb; 32(2):131-6. PubMed ID: 15606671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
